Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
Many mechanisms have been proposed to explain why immune responses against human tumor antigens are generally ineffective. For example, tumor cells have been shown to develop active immune evasion mechanisms. Another possibility is that tumor antigens are unable to optimally stimulate tumor-specific...
Հիմնական հեղինակներ: | Valmori, D, Fonteneau, J, Valitutti, S, Gervois, N, Dunbar, R, Liénard, D, Rimoldi, D, Cerundolo, V, Jotereau, F, Cerottini, J, Speiser, D, Romero, P |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
1999
|
Նմանատիպ նյութեր
-
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
: Valmori, D, և այլն
Հրապարակվել է: (1999) -
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
: Valmori, D, և այլն
Հրապարակվել է: (2000) -
An antigen-targeted approach to adoptive transfer therapy of cancer.
: Valmori, D, և այլն
Հրապարակվել է: (1999) -
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
: Romero, P, և այլն
Հրապարակվել է: (1998) -
Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
: Valmori, D, և այլն
Հրապարակվել է: (1999)